Es gab 50 kürzliche Insider-Transaktionen für Apogee Therapeutics, Inc. (APGE), darunter 12 Käufe und 38 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $36.44M und die gesamten Insider-Verkäufe auf $141.26M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Henderson Jane, Dambkowski Carl, Henderson Michael Thomas. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — APGE
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-04-01 |
Henderson Jane |
Chief Financial Officer |
Informierter Verkauf |
1,100 |
$85.46 |
$94.01K |
177,371 |
| 2026-04-01 |
Dambkowski Carl |
Chief Medical Officer |
Optionsausübung (Verkauf) |
4,125 |
$22.86 |
$94.3K |
127,165 |
| 2026-03-25 |
Henderson Jane |
Chief Financial Officer |
Informierter Verkauf |
2,000 |
$85.00 |
$170K |
179,371 |
| 2026-03-11 |
Henderson Michael Thomas |
Chief Executive Officer |
Informierter Verkauf |
3,418 |
$75.86 |
$259.29K |
1,152,987 |
| 2026-03-04 |
Dambkowski Carl |
Chief Medical Officer |
Optionsausübung (Verkauf) |
4,125 |
$22.86 |
$94.3K |
131,290 |
| 2026-03-02 |
Henderson Jane |
Chief Financial Officer |
Informierter Verkauf |
406 |
$71.66 |
$29.09K |
181,371 |
| 2026-02-11 |
Henderson Michael Thomas |
Chief Executive Officer |
Informierter Verkauf |
955 |
$64.99 |
$62.07K |
1,172,987 |
| 2026-02-04 |
Dambkowski Carl |
Chief Medical Officer |
Optionsausübung (Verkauf) |
4,125 |
$22.86 |
$94.3K |
135,415 |
| 2026-02-02 |
Henderson Jane |
Chief Financial Officer |
Informierter Verkauf |
100 |
$66.89 |
$6.69K |
183,371 |
| 2026-01-22 |
Fairmount Funds Management Llc |
Director |
Informierter Verkauf |
1,750,000 |
$76.30 |
$133.53M |
298,647 |
| 2026-01-14 |
Henderson Michael Thomas |
Chief Executive Officer |
Informierter Verkauf |
470 |
$83.79 |
$39.38K |
1,192,987 |
| 2026-01-07 |
Dambkowski Carl |
Chief Medical Officer |
Optionsausübung (Verkauf) |
14,025 |
$22.86 |
$320.61K |
139,540 |
| 2026-01-06 |
Henderson Jane |
Chief Financial Officer |
Informierter Verkauf |
2,000 |
$80.00 |
$160K |
185,371 |
| 2026-01-02 |
Henderson Jane |
Chief Financial Officer |
RSU-Zuteilung |
83,690 |
$75.78 |
$6.34M |
83,690 |
| 2026-01-02 |
Henderson Michael Thomas |
Chief Executive Officer |
RSU-Zuteilung |
253,016 |
$75.78 |
$19.17M |
253,016 |
| 2026-01-02 |
Dambkowski Carl |
Chief Medical Officer |
RSU-Zuteilung |
83,690 |
$75.78 |
$6.34M |
83,690 |
| 2025-12-19 |
Henderson Jane |
Chief Financial Officer |
Informierter Verkauf |
1,500 |
$80.00 |
$120K |
193,371 |
| 2025-12-10 |
Henderson Michael Thomas |
Chief Executive Officer |
Informierter Verkauf |
560 |
$76.58 |
$42.88K |
1,212,987 |
| 2025-12-04 |
Henderson Jane |
Chief Financial Officer |
Informierter Verkauf |
1,500 |
$75.00 |
$112.5K |
194,871 |
| 2025-12-04 |
Henderson Michael Thomas |
Chief Executive Officer |
Informierter Verkauf |
40,000 |
$75.01 |
$3M |
1,232,987 |
| 2025-12-04 |
Dambkowski Carl |
Chief Medical Officer |
Informierter Verkauf |
10,900 |
$75.00 |
$817.5K |
271,108 |
| 2025-11-25 |
Henderson Jane |
Chief Financial Officer |
Informierter Verkauf |
1,500 |
$70.00 |
$105K |
196,371 |
| 2025-11-14 |
Henderson Jane |
Chief Financial Officer |
Informierter Verkauf |
2,000 |
$65.00 |
$130K |
197,871 |
| 2025-11-13 |
Henderson Michael Thomas |
Chief Executive Officer |
Informierter Verkauf |
100 |
$64.52 |
$6.45K |
1,272,987 |
| 2025-11-11 |
Henderson Jane |
Chief Financial Officer |
Informierter Verkauf |
1,000 |
$60.00 |
$60K |
199,871 |
| 2025-11-05 |
Dambkowski Carl |
Chief Medical Officer |
Optionsausübung (Verkauf) |
8,060 |
$22.86 |
$184.25K |
153,565 |
| 2025-10-10 |
Shah Nimish P |
Director |
Informierter Kauf |
365,853 |
- |
- |
365,853 |
| 2025-10-01 |
Dambkowski Carl |
Chief Medical Officer |
Optionsausübung (Verkauf) |
2,385 |
$22.86 |
$54.52K |
161,625 |
| 2025-09-03 |
Dambkowski Carl |
Chief Medical Officer |
Informierter Verkauf |
190 |
$38.55 |
$7.32K |
233,548 |
| 2025-08-06 |
Dambkowski Carl |
Chief Medical Officer |
Informierter Verkauf |
2,725 |
$37.78 |
$102.95K |
236,273 |
| 2025-07-02 |
Dambkowski Carl |
Chief Medical Officer |
Optionsausübung (Verkauf) |
7,365 |
$22.86 |
$168.36K |
164,010 |
| 2025-06-17 |
Jones William A Jr |
Director |
RSU-Zuteilung |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Shah Nimish P |
Director |
RSU-Zuteilung |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Mckenna Mark C. |
Director |
RSU-Zuteilung |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Fairmount Funds Management Llc |
Director |
RSU-Zuteilung |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Fox Jennifer A. |
Director |
RSU-Zuteilung |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Gottesdiener Andrew |
Director |
RSU-Zuteilung |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Bollinger Lisa |
Director |
RSU-Zuteilung |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-04 |
Dambkowski Carl |
Chief Medical Officer |
Informierter Verkauf |
2,725 |
$36.96 |
$100.72K |
241,723 |
| 2025-05-07 |
Dambkowski Carl |
Chief Medical Officer |
Informierter Verkauf |
2,725 |
$35.75 |
$97.42K |
244,448 |
| 2025-04-02 |
Dambkowski Carl |
Chief Medical Officer |
Informierter Verkauf |
889 |
$37.59 |
$33.42K |
247,173 |
| 2025-03-05 |
Henderson Michael Thomas |
Chief Executive Officer |
Informierter Verkauf |
2,674 |
$30.62 |
$81.88K |
1,292,987 |
| 2025-03-05 |
Dambkowski Carl |
Chief Medical Officer |
Informierter Verkauf |
1,590 |
$30.48 |
$48.46K |
251,033 |
| 2025-02-05 |
Henderson Michael Thomas |
Chief Executive Officer |
Informierter Verkauf |
15,000 |
$40.58 |
$608.7K |
1,302,987 |
| 2025-02-05 |
Dambkowski Carl |
Chief Medical Officer |
Optionsausübung (Verkauf) |
795 |
$22.86 |
$18.17K |
171,375 |
| 2025-01-31 |
Henderson Michael Thomas |
Chief Executive Officer |
Optionsausübung (Verkauf) |
8,500 |
$22.86 |
$194.31K |
390,012 |
| 2025-01-08 |
Henderson Michael Thomas |
Chief Executive Officer |
Informierter Verkauf |
2,868 |
$49.38 |
$141.62K |
1,309,487 |
| 2025-01-02 |
Dambkowski Carl |
Chief Medical Officer |
Optionsausübung (Verkauf) |
1,360 |
$22.86 |
$31.09K |
172,170 |
| 2024-12-12 |
Mckenna Mark C. |
Director |
Informierter Kauf |
7,500 |
$49.02 |
$367.65K |
7,500 |
| 2024-12-11 |
Dambkowski Carl |
Chief Medical Officer |
Optionsausübung (Verkauf) |
1,815 |
$22.86 |
$41.49K |
173,530 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
